Atea Pharmaceuticals annual total assets
2019
2020
2021
2022
2023
2024
2025
Atea Pharmaceuticals Total Assets Growth & History (AVIR)
Atea Pharmaceuticals's total assets was $315.2M for fiscal 2025.
View full Atea Pharmaceuticals company overviewAtea Pharmaceuticals annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $315.2M | −$149.4M | −32.16% |
| 2024 | 2024-12-31 | $464.7M | −$130.3M | −21.90% |
| 2023 | 2023-12-31 | $595.0M | −$71.7M | −10.76% |
| 2022 | 2022-12-31 | $666.7M | −$106.2M | −13.74% |
| 2021 | 2021-12-31 | $772.9M | −$90.7M | −10.51% |
| 2020 | 2020-12-31 | $863.6M | $841.6M | +3812.62% |
| 2019 | 2019-12-31 | $22.1M | — | — |
Atea Pharmaceuticals quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $232.3M | −$159.3M | −40.68% |
| Q1 2026 | 2026-03-31 | $267.1M | −$172.9M | −39.30% |
| Q4 2025 | 2025-12-31 | $315.2M | −$149.4M | −32.16% |
| Q3 2025 | 2025-09-30 | $343.0M | −$148.0M | −30.14% |
| Q2 2025 | 2025-06-30 | $391.6M | −$118.8M | −23.27% |
| Q1 2025 | 2025-03-31 | $440.0M | −$113.1M | −20.44% |
| Q4 2024 | 2024-12-31 | $464.7M | −$130.3M | −21.90% |
| Q3 2024 | 2024-09-30 | $491.0M | −$117.1M | −19.26% |
| Q2 2024 | 2024-06-30 | $510.4M | −$115.6M | −18.47% |
| Q1 2024 | 2024-03-31 | $553.0M | −$85.1M | −13.34% |
| Q4 2023 | 2023-12-31 | $595.0M | −$71.7M | −10.76% |
| Q3 2023 | 2023-09-30 | $608.1M | −$78.5M | −11.43% |
| Q2 2023 | 2023-06-30 | $626.0M | −$68.3M | −9.84% |
| Q1 2023 | 2023-03-31 | $638.1M | −$79.1M | −11.02% |
| Q4 2022 | 2022-12-31 | $666.7M | −$106.2M | −13.74% |
| Q3 2022 | 2022-09-30 | $686.6M | −$156.9M | −18.60% |
| Q2 2022 | 2022-06-30 | $694.3M | −$177.2M | −20.33% |
| Q1 2022 | 2022-03-31 | $717.2M | −$123.5M | −14.69% |
| Q4 2021 | 2021-12-31 | $772.9M | −$90.7M | −10.51% |
| Q3 2021 | 2021-09-30 | $843.5M | $733.4M | +666.08% |
| Q2 2021 | 2021-06-30 | $871.5M | — | — |
| Q1 2021 | 2021-03-31 | $840.6M | — | — |
| Q4 2020 | 2020-12-31 | $863.6M | $841.6M | +3812.62% |
| Q3 2020 | 2020-09-30 | $110.1M | — | — |
| Q4 2019 | 2019-12-31 | $22.1M | — | — |
Atea Pharmaceuticals total assets trends
Over the last five fiscal years, Atea Pharmaceuticals's total assets decreased from $863.6M to $315.2M, a change of −$548.4M. The latest reported quarter, Q2 2026, shows $232.3M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Atea Pharmaceuticals source filings ↗